OrbiMed Advisors LLC, a director at Sionna Therapeutics , Inc. (NASDAQ:SION), has made significant stock purchases, according to a recent filing. On February 10, 2025, OrbiMed acquired 550,000 shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback